Bio-Rad Laboratories, Inc. (BIO.B)

Bio-Rad Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,554	2,567	2,671	2,802	2,923	2,546
Revenue Growth (YoY)	-0.33%	-3.92%	-4.67%	-4.12%	14.81%	10.12%
Cost of Revenue	1,202	1,188	1,244	1,235	1,259	1,108
Gross Profit	1,353	1,379	1,427	1,567	1,663	1,438
Selling, General & Admin	806.1	814	841.7	827.8	851.02	798.8
Research & Development	293.1	295.9	247.4	256.9	247.34	217.76
Operating Expenses	1,099	1,110	1,089	1,085	1,098	1,017
Operating Income	253.5	269	337.8	482.6	564.74	421.33
Interest Expense	-49	-48.9	-49.4	-38.1	-1.55	-21.86
Interest & Investment Income	82.3	82	100.9	58.1	18.9	18.2
Currency Exchange Gain (Loss)	1.8	3.9	7.3	0.2	-2.75	-1.77
Other Non Operating Income (Expenses)	0.5	1.6	4.9	-5.2	0.68	-1.81
EBT Excluding Unusual Items	289.1	307.6	401.5	497.6	580.01	414.08
Merger & Restructuring Charges	-29.9	-	-	-	-64.4	-
Gain (Loss) on Sale of Investments	190.9	-2,650	-1,252	-5,203	4,933	4,492
Gain (Loss) on Sale of Assets	-	-	-	1.4	-	11.7
Pretax Income	450.1	-2,343	-850.1	-4,704	5,449	4,918
Income Tax Expense	130.9	-498.3	-212.8	-1,077	1,195	1,104
Net Income	319.2	-1,844	-637.3	-3,628	4,254	3,814
Net Income to Common	319.2	-1,844	-637.3	-3,628	4,254	3,814
Net Income Growth	-	-	-	-	11.54%	116.88%
Shares Outstanding (Basic)	28	28	29	30	30	30
Shares Outstanding (Diluted)	28	28	29	30	30	30
Shares Change (YoY)	-3.21%	-3.41%	-1.93%	-1.40%	0.16%	-0.08%
EPS (Basic)	11.49	-65.36	-21.82	-121.79	142.61	128.13
EPS (Diluted)	11.49	-65.36	-21.82	-121.79	140.83	126.47
EPS Growth	-	-	-	-	11.35%	117.04%
Free Cash Flow	371	289.6	218.2	81.6	535.75	476.44
Free Cash Flow Per Share	13.36	10.26	7.47	2.74	17.74	15.80
Gross Margin	52.96%	53.73%	53.42%	55.93%	56.91%	56.48%
Operating Margin	9.93%	10.48%	12.65%	17.22%	19.32%	16.55%
Profit Margin	12.50%	-71.86%	-23.86%	-129.45%	145.57%	149.84%
Free Cash Flow Margin	14.52%	11.28%	8.17%	2.91%	18.33%	18.72%
EBITDA	410.3	420.6	483.7	619.9	702.34	559.93
EBITDA Margin	16.06%	16.39%	18.11%	22.12%	24.03%	22.00%
D&A For EBITDA	156.8	151.6	145.9	137.3	137.6	138.6
EBIT	253.5	269	337.8	482.6	564.74	421.33
EBIT Margin	9.93%	10.48%	12.65%	17.22%	19.32%	16.55%
Effective Tax Rate	29.08%	-	-	-	21.93%	22.44%

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q